Speaker Portals: Cut Costs and Build Relationships

Historically, pharmaceutical companies have depended on disparate systems for speakers and consultants.  Contracting and management of these HCPs, whose roles frequently overlap and are difficult to track.  With Sunshine Act reporting now required, pharmaceutical companies need to have a singular, consolidated view of their engagement with contracted HCPs.

The pharmaceutical leaders in HCP contractor consolidation have been pushed to change thanks to cost containment tactics that procurement departments have mandated.  Fortunately, new online tools are emerging to help companies quickly centralize the functions of contracting, training, and utilization that brand teams previously had to manage on their own.    

The benefits of implementing a consolidated Speaker Portal system for managing speakers and consultants are compelling:

1. Consistent contractor communications

2. Standardized training that can be delivered more efficiently

3. Real-time utilization and payment tracking of contractors, with feeds to  Aggregate Spend

4. Speaker and consultant preference profiling (from travel details to training preferences to specialized expertise)

 Accenture’s March 2013 pharmaceutical management survey “Life in the New Normal: The Customer Engagement Revolution” reported:

…“83 percent of the executives said cost reduction was the highest strategic priority for them in 2013, followed by mastering multichannel marketing (70 percent) and improving digital effectiveness (60 percent).  Executives expect to meet their cost reduction goals by increasing their use of analytics, digital, multichannel marketing and third-party service providers. “

2013 pharmaceutical company imperatives focused on cost reduction and analytics.  We’re predicting that 2014 will be a big year for HCP contractor data consolidation and management.  The pharmaceutical companies that jump on board will find increased operational efficiencies and cost savings of at least 30%.  With those improved efficiencies, brand managers can spend more time where it matters: building stronger relationships with their KOLs.

ABOUT THE AUTHOR

Picture of Daniel J. Rehal

Daniel J. Rehal

As President of Vision2Voice, Daniel thoroughly understands the pharmaceutical industry from the ground floor up. By ascending the ranks at Merck to his global responsibilities at Takeda, Dan has significant experience in both marketing and sales roles supporting a multitude of pharmaceutical brands as an award-winning Sales Representative, Training Manager, District Manager, Senior Product Manager, and Marketing Director.

Recent Posts

V2V President Daniel Rehal holds the 2024 BBB Torch Award for Ethics and Excellence

V2V Wins 2024 Better Business Bureau Torch Award for Ethics and Excellence

“The Torch Award is the most valuable award for any business. It honors our culture and values by recognizing that our ethical business practices matter...

Read More

Roundtable Q&A with V2V’s Technology Innovation Team

In the fast-evolving world of MedComm, innovation is more than a buzzword—it’s a necessity. At Vision2Voice (V2V), innovation means harnessing the latest technology to simplify...

Read More
V2V Team

Build Your Culture with the Right People – Dan Recommends

Talking about ethics might not be the most exciting topic, but it’s crucial. Leaders often find it more appealing to focus on growth and achievements...

Read More